These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 22433895)
1. Reduced susceptibility of Malaysian clinical isolates of Burkholderia pseudomallei to ciprofloxacin. Liew FY; Tay ST; Puthucheary SD Trop Biomed; 2011 Dec; 28(3):646-50. PubMed ID: 22433895 [TBL] [Abstract][Full Text] [Related]
2. Antibiotic susceptibility of 50 clinical isolates of Burkholderia pseudomallei from Singapore. Sivalingam SP; Sim SH; Aw LT; Ooi EE J Antimicrob Chemother; 2006 Nov; 58(5):1102-3. PubMed ID: 16951412 [No Abstract] [Full Text] [Related]
3. Antimicrobial susceptibility patterns of Burkholderia pseudomallei among melioidosis cases in Kedah, Malaysia. Hassan MR; Vijayalakshmi N; Pani SP; Peng NP; Mehenderkar R; Voralu K; Michael E Southeast Asian J Trop Med Public Health; 2014 May; 45(3):680-8. PubMed ID: 24974653 [TBL] [Abstract][Full Text] [Related]
4. Five-year surveillance for Burkholderia pseudomallei in Thailand from 2000 to 2004: prevalence and antimicrobial susceptibility. Paveenkittiporn W; Apisarnthanarak A; Dejsirilert S; Trakulsomboon S; Thongmali O; Sawanpanyalert P; Aswapokee N J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S46-52. PubMed ID: 21298845 [TBL] [Abstract][Full Text] [Related]
5. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi. Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513 [TBL] [Abstract][Full Text] [Related]
6. Cases of melioidosis in a university teaching hospital in Malaysia. Raja NS J Microbiol Immunol Infect; 2008 Apr; 41(2):174-9. PubMed ID: 18473106 [TBL] [Abstract][Full Text] [Related]
7. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia. Crowe A; McMahon N; Currie BJ; Baird RW Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662 [TBL] [Abstract][Full Text] [Related]
8. Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia. Hassing RJ; Menezes GA; van Pelt W; Petit PL; van Genderen PJ; Goessens WH Int J Antimicrob Agents; 2011 Mar; 37(3):240-3. PubMed ID: 21227657 [TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of moxifloxacin resistance from Canadian Clostridium difficile clinical isolates. Walkty A; Boyd DA; Gravel D; Hutchinson J; McGeer A; Moore D; Simor A; Suh K; Taylor G; Miller M; Mulvey MR; Diagn Microbiol Infect Dis; 2010 Apr; 66(4):419-24. PubMed ID: 20226332 [TBL] [Abstract][Full Text] [Related]
10. Burkholderia pseudomallei: in vitro susceptibility to some new and old antimicrobials. Karunakaran R; Puthucheary SD Scand J Infect Dis; 2007; 39(10):858-61. PubMed ID: 17852912 [TBL] [Abstract][Full Text] [Related]
11. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes typhi and paratyphi A isolated from the Infectious Diseases Hospital, Kuwait. Dimitrov T; Dashti AA; Albaksami O; Jadaon MM J Clin Pathol; 2010 Jan; 63(1):83-7. PubMed ID: 19889623 [TBL] [Abstract][Full Text] [Related]
12. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets. Turner AK; Nair S; Wain J J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934 [TBL] [Abstract][Full Text] [Related]
13. Complete nucleotide sequence of the gyrA gene of Helicobacter pullorum and identification of a point mutation leading to ciprofloxacin resistance in poultry isolates. Pasquali F; Rossi M; Manfreda G; Zanoni R Int J Antimicrob Agents; 2007 Sep; 30(3):222-8. PubMed ID: 17644320 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea. Jeong HS; Kim JA; Shin JH; Chang CL; Jeong J; Cho JH; Kim MN; Kim S; Kim YR; Lee CH; Lee K; Lee MA; Lee WG; Shin JH; Lee JN Microb Drug Resist; 2011 Dec; 17(4):551-7. PubMed ID: 21830947 [TBL] [Abstract][Full Text] [Related]
15. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents. Thibault FM; Hernandez E; Vidal DR; Girardet M; Cavallo JD J Antimicrob Chemother; 2004 Dec; 54(6):1134-8. PubMed ID: 15509614 [TBL] [Abstract][Full Text] [Related]
16. Burkholderia pseudomallei animal and human isolates from Malaysia exhibit different phenotypic characteristics. Lee SH; Chong CE; Lim BS; Chai SJ; Sam KK; Mohamed R; Nathan S Diagn Microbiol Infect Dis; 2007 Jul; 58(3):263-70. PubMed ID: 17350202 [TBL] [Abstract][Full Text] [Related]
17. Genotypic and phenotypic relationship in Burkholderia pseudomallei indicates colonization with closely related isolates. Radu S; Lihan S; Idris A; Ling OW; Al-Haddawi MH; Rusul G Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):760-3. PubMed ID: 10928372 [TBL] [Abstract][Full Text] [Related]
18. Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates. Bansal S; Tandon V Int J Antimicrob Agents; 2011 Mar; 37(3):253-5. PubMed ID: 21236644 [TBL] [Abstract][Full Text] [Related]
19. PCR-restriction fragment length polymorphism assay for detection of gyrA mutations associated with fluoroquinolone resistance in Campylobacter coli. Alonso R; Mateo E; Girbau C; Churruca E; Martinez I; Fernández-Astorga A Antimicrob Agents Chemother; 2004 Dec; 48(12):4886-8. PubMed ID: 15561873 [TBL] [Abstract][Full Text] [Related]
20. Wide dissemination of multidrug-resistant Shigella isolates in China. Zhang W; Luo Y; Li J; Lin L; Ma Y; Hu C; Jin S; Ran L; Cui S J Antimicrob Chemother; 2011 Nov; 66(11):2527-35. PubMed ID: 21859815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]